Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F112 - Lichen Planus and Lichen Planopilaris: An Update

Sunday, February 18; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Define the clinical spectrum of lichen planus.
  • Diagnose various clinical types of lichen planus.
  • Choose adequate therapy for patients with lichen planopilaris and frontal fibrosing alopecia

Description

The clinical spectrum of lichen planus includes cutaneous lichen planus, mucous membrane lichen planus, lichen planopilaris, frontal fibrosing alopecia and lichen planus of the nails. New clinical manifestations of lichen planus have been described recently. The session is designed to present the clinical spectrum of the disease. New diagnostic approaches (dermoscopy, trichoscopy, SES-ANA) will be discussed. Treatment options will be presented.

Disclosures

  • Mirowski, Ginat W., MD, DMD: UpToDate, Inc. – O(H);
  • Pirmez, Rodrigo, MD: no financial relationships exist with commercial interests.
  • Rudnicka, Lidia, MD, PhD: Johnson & Johnson Pharmaceutical Research & Development – I(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – SP(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Lilly ICOS LLC – SP(Fees); Novartis – SP(Fees); Pierre Fabre Dermo Cosmetique France – Speaker/Faculty Education(OB); Stiefel a GSK company – A(Fees);
  • Shapiro, Jerry, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc. – A(H); Applied Biology – C(H); Bayer Consumer Healthcare Pharmaceuticals – C(NC); Bioniz Therapeutics – A(Fees); Cassiopea SpA – A(NC); Incyte Corporation – C(NC); Johnson & Johnson Consumer Products Company – C(H); L'Oréal France – C(H); RegenLab – I(Grants/Research Funding); RepliCel Life Sciences – F(ST); Samumed, LLC – A(H);
  • Tosti, Antonella, MD: Aclaris Therapeutics, Inc. – A(H); Anacor Pharmaceuticals, Inc. – A(H); DS Laboratories – C(Fees); Fotofinder – C(EQ); Incyte Corporation – C(H); Kurt Wolff GmbH & Co. KG – A(H); Kythera – A(H); Meiji Seika Pharma Co., Ltd – A(H); MSD – SP(H); Novartis – A(H); PharmaDerm – Speaker/Faculty Education(H); Pierre Fabre Dermatologie – C(H); Polichem SA – A(H); Procter & Gamble Company – A(H); Springer Science & Business Media – O(IP); Taylor & Francis – O(IP); topica – C(Fees); Valeant Pharmaceuticals International – C(Fees); Viamet Pharmaceuticals, Inc – A(H);
Schedule
Sunday, February 18
3:30 PM
Dr. Rudnicka / Introduction
3:40 PM
Dr. Tosti / Lichen planus of the nails
4:00 PM
Dr. Mirowski / What’s new in oral lichen planus ?
4:20 PM
Dr. Pirmez / Lichen planus pigmentosus: from diagnosis to therapy
4:40 PM
Dr. Rudnicka / Frontal fibrosing alopecia: from diagnosis to therapy
5:00 PM
Dr. Shapiro / How do I treat lichen planopilaris ?
5:20 PM
All faculty / Q&A
Event Details
  • Date
    Sunday, February 18
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 32B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Lidia Rudnicka, MD, PhD
Speakers
  • Antonella Tosti, MD - Handout
  • Ginat W. Mirowski, MD, DMD, FAAD
  • Jerry Shapiro, MD, FAAD
  • Rodrigo Pirmez, MD - Handout